Amedeo Smart

Free Medical Literature Service


 

Amedeo

Vaccines

  Free Subscription

Articles published in
Proc Natl Acad Sci U S A
    October 2022
  1. YANG K, Wang C, Kreutzberger AJB, Ojha R, et al
    Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein.
    Proc Natl Acad Sci U S A. 2022;119:e2210990119.
    >> Share

    September 2022
  2. VAN BEEK M, Nussenzweig MC, Chakraborty AK
    Two complementary features of humoral immune memory confer protection against the same or variant antigens.
    Proc Natl Acad Sci U S A. 2022;119:e2205598119.
    >> Share

    August 2022
  3. LU M, Chamblee M, Zhang Y, Ye C, et al
    SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern.
    Proc Natl Acad Sci U S A. 2022;119:e2110105119.
    >> Share

  4. YANG Z, Wu D, Lu S, Qiu Y, et al
    Plasma metabolome and cytokine profile reveal glycylproline modulating antibody fading in convalescent COVID-19 patients.
    Proc Natl Acad Sci U S A. 2022;119:e2117089119.
    >> Share

  5. XIONG H, Sun H, Wang S, Yuan L, et al
    The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2022;119:e2204256119.
    >> Share

  6. CHEN J, Ye Z, Huang C, Qiu M, et al
    Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8(+) T cell response.
    Proc Natl Acad Sci U S A. 2022;119:e2207841119.
    >> Share

  7. ZHANG Y, Lu M, Mahesh KC, Kim E, et al
    A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike.
    Proc Natl Acad Sci U S A. 2022;119:e2201616119.
    >> Share

  8. BACKLUND CM, Holden RL, Moynihan KD, Garafola D, et al
    Cell-penetrating peptides enhance peptide vaccine accumulation and persistence in lymph nodes to drive immunogenicity.
    Proc Natl Acad Sci U S A. 2022;119:e2204078119.
    >> Share

  9. TOWNSEND JP, Hassler HB, Sah P, Galvani AP, et al
    The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2022;119:e2204336119.
    >> Share

    July 2022
  10. RABB N, Bowers J, Glick D, Wilson KH, et al
    The influence of social norms varies with "others" groups: Evidence from COVID-19 vaccination intentions.
    Proc Natl Acad Sci U S A. 2022;119:e2118770119.
    >> Share

  11. KARDAVA L, Rachmaninoff N, Lau WW, Buckner CM, et al
    Early human B cell signatures of the primary antibody response to mRNA vaccination.
    Proc Natl Acad Sci U S A. 2022;119:e2204607119.
    >> Share

    June 2022
  12. SIEWERT LK, Korotaev A, Sedzicki J, Fromm K, et al
    Identification of the Bartonella autotransporter CFA as a protective antigen and hypervariable target of neutralizing antibodies in mice.
    Proc Natl Acad Sci U S A. 2022;119:e2202059119.
    >> Share

  13. AMERICO JL, Cotter CA, Earl PL, Liu R, et al
    Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2022;119:e2202069119.
    >> Share

  14. OTIANG E, Yoder J, Manian S, Campbell ZA, et al
    Vaccination of household chickens results in a shift in young children's diet and improves child growth in rural Kenya.
    Proc Natl Acad Sci U S A. 2022;119:e2122389119.
    >> Share

  15. NARCISO AR, Iovino F, Thorsdottir S, Mellroth P, et al
    Membrane particles evoke a serotype-independent cross-protection against pneumococcal infection that is dependent on the conserved lipoproteins MalX and PrsA.
    Proc Natl Acad Sci U S A. 2022;119:e2122386119.
    >> Share

    May 2022
  16. HEKMATI A, Luhar M, Krishnamachari B, Mataric M, et al
    Simulating COVID-19 classroom transmission on a university campus.
    Proc Natl Acad Sci U S A. 2022;119:e2116165119.
    >> Share

  17. BAXTER-KING R, Brown JR, Enos RD, Naeim A, et al
    How local partisan context conditions prosocial behaviors: Mask wearing during COVID-19.
    Proc Natl Acad Sci U S A. 2022;119:e2116311119.
    >> Share

  18. ZHU X, Han J, Sun W, Puente-Massaguer E, et al
    Influenza chimeric hemagglutinin structures in complex with broadly protective antibodies to the stem and trimer interface.
    Proc Natl Acad Sci U S A. 2022;119:e2200821119.
    >> Share

  19. KINGSTAD-BAKKE B, Lee W, Chandrasekar SS, Gasper DJ, et al
    Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants.
    Proc Natl Acad Sci U S A. 2022;119:e2118312119.
    >> Share

  20. SPRECO A, Schon T, Timpka T
    Corruption should be taken into account when considering COVID-19 vaccine allocation.
    Proc Natl Acad Sci U S A. 2022;119:e2122664119.
    >> Share

  21. DUCH R, Robinson TS, Clarke PM, Roope LSJ, et al
    Reply to Spreco et al.: Perceived corruption and preferences for COVID-19 vaccine allocations.
    Proc Natl Acad Sci U S A. 2022;119:e2201847119.
    >> Share

    April 2022
  22. POSTIGO-FERNANDEZ J, Firdessa-Fite R, Creusot RJ
    Preclinical evaluation of a precision medicine approach to DNA vaccination in type 1 diabetes.
    Proc Natl Acad Sci U S A. 2022;119:e2110987119.
    >> Share

  23. ROBINSON PC, Liew DFL, Tanner HL, Grainger JR, et al
    COVID-19 therapeutics: Challenges and directions for the future.
    Proc Natl Acad Sci U S A. 2022;119:e2119893119.
    >> Share

  24. TEPLENSKY MH, Distler ME, Kusmierz CD, Evangelopoulos M, et al
    Spherical nucleic acids as an infectious disease vaccine platform.
    Proc Natl Acad Sci U S A. 2022;119:e2119093119.
    >> Share

    March 2022
  25. KAVISHNA R, Kang TY, Vacca M, Chua BYL, et al
    A single-shot vaccine approach for the universal influenza A vaccine candidate M2e.
    Proc Natl Acad Sci U S A. 2022;119:e2025607119.
    >> Share

  26. SCHMELZ K, Bowles S
    Opposition to voluntary and mandated COVID-19 vaccination as a dynamic process: Evidence and policy implications of changing beliefs.
    Proc Natl Acad Sci U S A. 2022;119:e2118721119.
    >> Share

  27. FOSTER SL, Woolsey C, Borisevich V, Agans KN, et al
    A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease.
    Proc Natl Acad Sci U S A. 2022;119:e2200065119.
    >> Share

  28. LEWNARD JA, Fries LF, Cho I, Chen J, et al
    Prevention of antimicrobial prescribing among infants following maternal vaccination against respiratory syncytial virus.
    Proc Natl Acad Sci U S A. 2022;119:e2112410119.
    >> Share

  29. WANG X, Li P, Singh AK, Zhang X, et al
    Remodeling Yersinia pseudotuberculosis to generate a highly immunogenic outer membrane vesicle vaccine against pneumonic plague.
    Proc Natl Acad Sci U S A. 2022;119:e2109667119.
    >> Share

  30. WANG R, Suzuki S, Guest JD, Heller B, et al
    Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidate.
    Proc Natl Acad Sci U S A. 2022;119:e2112008119.
    >> Share

  31. SHAN S, Luo S, Yang Z, Hong J, et al
    Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization.
    Proc Natl Acad Sci U S A. 2022;119:e2122954119.
    >> Share

  32. WU CY, Cheng CW, Kung CC, Liao KS, et al
    Glycosite-deleted mRNA of SARS-CoV-2 spike protein as a broad-spectrum vaccine.
    Proc Natl Acad Sci U S A. 2022;119.
    >> Share

  33. PETERSEN GEL, Buntjer JB, Hely FS, Byrne TJ, et al
    Modeling suggests gene editing combined with vaccination could eliminate a persistent disease in livestock.
    Proc Natl Acad Sci U S A. 2022;119.
    >> Share

    February 2022
  34. WIECEK W, Ahuja A, Chaudhuri E, Kremer M, et al
    Testing fractional doses of COVID-19 vaccines.
    Proc Natl Acad Sci U S A. 2022;119.
    >> Share

  35. DEVARAJAN P, Vong AM, Castonguay CH, Kugler-Umana O, et al
    Strong influenza-induced TFH generation requires CD4 effectors to recognize antigen locally and receive signals from continuing infection.
    Proc Natl Acad Sci U S A. 2022;119.
    >> Share

  36. HOFF NA, Bratcher A, Kelly JD, Musene K, et al
    Immunogenicity of rVSVDeltaG-ZEBOV-GP Ebola vaccination in exposed and potentially exposed persons in the Democratic Republic of the Congo.
    Proc Natl Acad Sci U S A. 2022;119.
    >> Share

  37. MILKMAN KL, Gandhi L, Patel MS, Graci HN, et al
    A 680,000-person megastudy of nudges to encourage vaccination in pharmacies.
    Proc Natl Acad Sci U S A. 2022;119.
    >> Share

  38. MILDER FJ, Jongeneelen M, Ritschel T, Bouchier P, et al
    Universal stabilization of the influenza hemagglutinin by structure-based redesign of the pH switch regions.
    Proc Natl Acad Sci U S A. 2022;119.
    >> Share

  39. BEANS C
    Researchers getting closer to a "universal" flu vaccine.
    Proc Natl Acad Sci U S A. 2022;119.
    >> Share

    January 2022
  40. VARRELMAN TJ, Remien CH, Basinski AJ, Gorman S, et al
    Quantifying the effectiveness of betaherpesvirus-vectored transmissible vaccines.
    Proc Natl Acad Sci U S A. 2022;119.
    >> Share

  41. GANDON S, Lion S
    Targeted vaccination and the speed of SARS-CoV-2 adaptation.
    Proc Natl Acad Sci U S A. 2022;119.
    >> Share

  42. HUPERT N, Marin-Hernandez D, Gao B, Aguas R, et al
    Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave.
    Proc Natl Acad Sci U S A. 2022;119.
    >> Share

    December 2021
  43. SHAFFER L
    Inner Workings: Using vaccines to harness the immune system and fight drugs of abuse.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  44. JAMIESON KH, Romer D, Jamieson PE, Winneg KM, et al
    The role of non-COVID-specific and COVID-specific factors in predicting a shift in willingness to vaccinate: A panel study.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  45. SALOMON JA, Reinhart A, Bilinski A, Chua EJ, et al
    The US COVID-19 Trends and Impact Survey: Continuous real-time measurement of COVID-19 symptoms, risks, protective behaviors, testing, and vaccination.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  46. NAIR P
    QnAs with Katalin Kariko.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  47. LIU X, Luongo C, Matsuoka Y, Park HS, et al
    A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  48. CHU J, Pink SL, Willer R
    Religious identity cues increase vaccination intentions and trust in medical experts among American Christians.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  49. BOKEMPER SE, Gerber AS, Omer SB, Huber GA, et al
    Persuading US White evangelicals to vaccinate for COVID-19: Testing message effectiveness in fall 2020 and spring 2021.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    November 2021
  50. NARR K, Ertuna YI, Fallet B, Cornille K, et al
    Vaccine-elicited CD4 T cells prevent the deletion of antiviral B cells in chronic infection.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  51. ADAM D
    News Feature: Biology research, no cells required: By borrowing the machinery of life from broken cells, researchers are producing novel proteins, cheap lab reagents, and just-add-water vaccines.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  52. PEDERSON T
    A layperson encounter, on the "modified" RNA world.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  53. XIA D, Jin R, Byagathvalli G, Yu H, et al
    An ultra-low-cost electroporator with microneedle electrodes (ePatch) for SARS-CoV-2 vaccination.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  54. PISHESHA N, Harmand TJ, Rothlauf PW, Praest P, et al
    A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variants.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    October 2021
  55. GUTIERREZ-ALVAREZ J, Honrubia JM, Sanz-Bravo A, Gonzalez-Miranda E, et al
    Middle East respiratory syndrome coronavirus vaccine based on a propagation-defective RNA replicon elicited sterilizing immunity in mice.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  56. HUGHES MT, Auwaerter PG, Ehmann MR, Garibaldi BT, et al
    Opinion: The importance of offering vaccine choice in the fight against COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  57. HENSEN L, Nguyen THO, Rowntree LC, Damelang T, et al
    Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous Australians.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  58. GARCIA-SASTRE A
    Genomics serology to inform therapies and vaccines for arthritogenic alphaviruses.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    September 2021
  59. CAUDILL C, Perry JL, Iliadis K, Tessema AT, et al
    Transdermal vaccination via 3D-printed microneedles induces potent humoral and cellular immunity.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  60. GOLDMAN E
    How the unvaccinated threaten the vaccinated for COVID-19: A Darwinian perspective.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  61. KING HAD, Joyce MG, Lakhal-Naouar I, Ahmed A, et al
    Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  62. DUCH R, Roope LSJ, Violato M, Fuentes Becerra M, et al
    Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  63. DALVIE NC, Rodriguez-Aponte SA, Hartwell BL, Tostanoski LH, et al
    Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  64. KLUVER H, Hartmann F, Humphreys M, Geissler F, et al
    Incentives can spur COVID-19 vaccination uptake.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  65. XU S, McGinnis KR, Liu Y, Huang P, et al
    Structural basis of P[II] rotavirus evolution and host ranges under selection of histo-blood group antigens.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    August 2021
  66. SILVA PJS, Sagastizabal C, Nonato LG, Struchiner CJ, et al
    Optimized delay of the second COVID-19 vaccine dose reduces ICU admissions.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  67. KAUGARS K, Dardick J, de Oliveira AP, Weiss KA, et al
    A recombinant herpes virus expressing influenza hemagglutinin confers protection and induces antibody-dependent cellular cytotoxicity.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  68. AGARWAL R, Dugas M, Ramaprasad J, Luo J, et al
    Socioeconomic privilege and political ideology are associated with racial disparity in COVID-19 vaccination.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  69. ASHWORTH M, Thunstrom L, Cherry TL, Newbold SC, et al
    Emphasize personal health benefits to boost COVID-19 vaccination rates.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  70. PINK SL, Chu J, Druckman JN, Rand DG, et al
    Elite party cues increase vaccination intentions among Republicans.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share


  71. Correction for Madan et al., Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    July 2021
  72. STAQUICINI DI, Tang FHF, Markosian C, Yao VJ, et al
    Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  73. WANG Y, Yang C, Song Y, Coleman JR, et al
    Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  74. GOLDSTEIN JR, Cassidy T, Wachter KW
    Reply to Dushoff et al. and Pifarre i Arolas et al.: Age prioritization for COVID-19 vaccination does save lives and years of life.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  75. AROLAS HPI, Acosta E, Myrskyla M
    Optimal vaccination age varies across countries.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  76. DUSHOFF J, Colijn C, Earn DJD, Bolker BM, et al
    Transmission dynamics are crucial to COVID-19 vaccination policy.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  77. PETERSEN MB, Bor A, Jorgensen F, Lindholt MF, et al
    Transparent communication about negative features of COVID-19 vaccines decreases acceptance but increases trust.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  78. TSCHERNE A, Schwarz JH, Rohde C, Kupke A, et al
    Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    June 2021
  79. SCHMELZ K, Bowles S
    Overcoming COVID-19 vaccination resistance when alternative policies affect the dynamics of conformism, social norms, and crowding out.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  80. SATO-KANEKO F, Yao S, Lao FS, Nan J, et al
    Mitochondria-dependent synthetic small-molecule vaccine adjuvants for influenza virus infection.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  81. MCCARTHY KR, Von Holle TA, Sutherland LL, Oguin TH 3rd, et al
    Differential immune imprinting by influenza virus vaccination and infection in nonhuman primates.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  82. SIA ZR, He X, Zhang A, Ang JC, et al
    A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challenge.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    May 2021
  83. CHUMAKOV K, Avidan MS, Benn CS, Bertozzi SM, et al
    Old vaccines for new infections: Exploiting innate immunity to control COVID-19 and prevent future pandemics.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  84. MCDERMOTT A
    Core Concept: Herd immunity is an important-and often misunderstood-public health phenomenon.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  85. LABUDA JC, Pham OH, Depew CE, Fong KD, et al
    Circulating immunity protects the female reproductive tract from Chlamydia infection.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  86. MILKMAN KL, Patel MS, Gandhi L, Graci HN, et al
    A megastudy of text-based nudges encouraging patients to get vaccinated at an upcoming doctor's appointment.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  87. DONG C, Wang Y, Gonzalez GX, Ma Y, et al
    Intranasal vaccination with influenza HA/GO-PEI nanoparticles provides immune protection against homo- and heterologous strains.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  88. MAEDA DLNF, Tian D, Yu H, Dar N, et al
    Killed whole-genome reduced-bacteria surface-expressed coronavirus fusion peptide vaccines protect against disease in a porcine model.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    April 2021
  89. LIN X, Twelkmeyer T, Zhu D, Zhang L, et al
    Homeostatic regulation of T follicular helper and antibody response to particle antigens by IL-1Ra of medullary sinus macrophage origin.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  90. BUCKNER JH, Chowell G, Springborn MR
    Dynamic prioritization of COVID-19 vaccines when social distancing is limited for essential workers.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  91. CASTRO MC, Singer B
    Prioritizing COVID-19 vaccination by age.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  92. KORN L, Bohm R, Betsch C
    Reply to Rabb et al.: Why promoting COVID-19 vaccines with community immunity is not a good strategy (yet).
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    March 2021
  93. LU EY, Chen HH, Zhao H, Ozawa S, et al
    Health and economic impact of the pneumococcal conjugate vaccine in hindering antimicrobial resistance in China.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  94. BETSCH C, Korn L, Bohm R
    Reply to Weisel: From polarization to vaccination and back.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  95. WEISEL O
    Vaccination as a social contract: The case of COVID-19 and US political partisanship.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  96. LE NOUEN C, McCarty T, Yang L, Brown M, et al
    Rescue of codon-pair deoptimized respiratory syncytial virus by the emergence of genomes with very large internal deletions that complemented replication.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  97. LIU R, Americo JL, Cotter CA, Earl PL, et al
    One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  98. LU M, Dravid P, Zhang Y, Trivedi S, et al
    A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  99. GOLDSTEIN JR, Cassidy T, Wachter KW
    Vaccinating the oldest against COVID-19 saves both the most lives and most years of life.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  100. KAPLAN RM, Milstein A
    Influence of a COVID-19 vaccine's effectiveness and safety profile on vaccination acceptance.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  101. MADAN B, Zhang B, Xu K, Chao CW, et al
    Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  102. WU J, Bao C, Reinhardt RL, Abraham SN, et al
    Local induction of bladder Th1 responses to combat urinary tract infections.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  103. CONTI S, Kaczorowski KJ, Song G, Porter K, et al
    Design of immunogens to elicit broadly neutralizing antibodies against HIV targeting the CD4 binding site.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    February 2021
  104. FREYN AW, Han J, Guthmiller JJ, Bailey MJ, et al
    Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  105. BURTON DR
    A new lease on life for an HIV-neutralizing antibody class and vaccine target.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  106. SIT B, Fakoya B, Zhang T, Billings G, et al
    Dissecting serotype-specific contributions to live oral cholera vaccine efficacy.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  107. ZHANG H, You X, Wang X, Cui L, et al
    Delivery of mRNA vaccine with a lipid-like material potentiates antitumor efficacy through Toll-like receptor 4 signaling.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  108. MURAKOWSKI DK, Barton JP, Peter L, Chandrashekar A, et al
    Adenovirus-vectored vaccine containing multidimensionally conserved parts of the HIV proteome is immunogenic in rhesus macaques.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    January 2021
  109. HANNA CC, Ashhurst AS, Quan D, Maxwell JWC, et al
    Synthetic protein conjugate vaccines provide protection against Mycobacterium tuberculosis in mice.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  110. RAPPUOLI R, De Gregorio E, Del Giudice G, Phogat S, et al
    Vaccinology in the post-COVID-19 era.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  111. PERSSON BD, John L, Rafie K, Strebl M, et al
    Human species D adenovirus hexon capsid protein mediates cell entry through a direct interaction with CD46.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  112. GUEST JD, Wang R, Elkholy KH, Chagas A, et al
    Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimer.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  113. SU H, Liu Q, Bian X, Wang S, et al
    Synthesis and delivery of Streptococcus pneumoniae capsular polysaccharides by recombinant attenuated Salmonella vaccines.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  114. JUNG H, Albarracin D
    Concerns for others increases the likelihood of vaccination against influenza and COVID-19 more in sparsely rather than densely populated areas.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    December 2020
  115. BOZHANOVA NG, Sangha AK, Sevy AM, Gilchuk P, et al
    Discovery of Marburg virus neutralizing antibodies from virus-naive human antibody repertoires using large-scale structural predictions.
    Proc Natl Acad Sci U S A. 2020;117:31142-31148.
    >> Share

    November 2020
  116. HORNER C, Schurmann C, Auste A, Ebenig A, et al
    A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine.
    Proc Natl Acad Sci U S A. 2020 Nov 30. pii: 2014468117.
    >> Share

  117. LI W, Chen C, Drelich A, Martinez DR, et al
    Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2020;117:29832-29838.
    >> Share

  118. HENRIQUES P, Dello Iacono L, Gimeno A, Biolchi A, et al
    Structure of a protective epitope reveals the importance of acetylation of Neisseria meningitidis serogroup A capsular polysaccharide.
    Proc Natl Acad Sci U S A. 2020;117:29795-29802.
    >> Share

  119. GILBERT M, Sulikhan N, Uphyrkina O, Goncharuk M, et al
    Distemper, extinction, and vaccination of the Amur tiger.
    Proc Natl Acad Sci U S A. 2020 Nov 23. pii: 2000153117.
    >> Share

  120. MASTERS NB, Eisenberg MC, Delamater PL, Kay M, et al
    Fine-scale spatial clustering of measles nonvaccination that increases outbreak potential is obscured by aggregated reporting data.
    Proc Natl Acad Sci U S A. 2020;117:28506-28514.
    >> Share

  121. DATTA R, Roy Chowdhury R, Manjunath K, Hanna LE, et al
    A facile method of mapping HIV-1 neutralizing epitopes using chemically masked cysteines and deep sequencing.
    Proc Natl Acad Sci U S A. 2020 Nov 9. pii: 2010256117.
    >> Share

    October 2020
  122. KAHN JP, Henry LM, Mastroianni AC, Chen WH, et al
    Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development.
    Proc Natl Acad Sci U S A. 2020 Oct 29. pii: 2021189117.
    >> Share

  123. CHENG Q, Trangucci R, Nelson KN, Fu W, et al
    Prenatal and early-life exposure to the Great Chinese Famine increased the risk of tuberculosis in adulthood across two generations.
    Proc Natl Acad Sci U S A. 2020 Oct 19. pii: 2008336117.
    >> Share

  124. AFFANDI AJ, Grabowska J, Olesek K, Lopez Venegas M, et al
    Selective tumor antigen vaccine delivery to human CD169(+) antigen-presenting cells using ganglioside-liposomes.
    Proc Natl Acad Sci U S A. 2020 Oct 16. pii: 2006186117.
    >> Share


  125. Correction for Escobar et al., BCG vaccine protection from severe coronavirus disease 2019 (COVID-19).
    Proc Natl Acad Sci U S A. 2020 Oct 12. pii: 2019438117.
    >> Share

    September 2020
  126. LINDESTAM ARLEHAMN CS, Sette A, Peters B
    Lack of evidence for BCG vaccine protection from severe COVID-19.
    Proc Natl Acad Sci U S A. 2020 Sep 29. pii: 2016733117.
    >> Share

  127. PATELLA V, Delfino G, Bruzzese D, Giuliano A, et al
    The bacillus Calmette-Guerin vaccination allows the innate immune system to provide protection from severe COVID-19 infection.
    Proc Natl Acad Sci U S A. 2020 Sep 29. pii: 2015234117.
    >> Share

  128. BARILLAS-MURY C, Escobar LE, Molina-Cruz A
    Reply to Patella et al. and Lindestam Arlehamn et al.: Complex pandemic dynamics and effect of bacillus Calmette-Guerin (BCG) vaccination on COVID-19 prevalence and mortality.
    Proc Natl Acad Sci U S A. 2020 Sep 29. pii: 2017197117.
    >> Share

  129. METRAS R, Edmunds WJ, Youssouffi C, Dommergues L, et al
    Estimation of Rift Valley fever virus spillover to humans during the Mayotte 2018-2019 epidemic.
    Proc Natl Acad Sci U S A. 2020;117:24567-24574.
    >> Share

  130. RAUSCH JW, Capoferri AA, Katusiime MG, Patro SC, et al
    Low genetic diversity may be an Achilles heel of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2020 Sep 21. pii: 2017726117.
    >> Share

  131. HUANG D, Abbott RK, Havenar-Daughton C, Skog PD, et al
    B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models.
    Proc Natl Acad Sci U S A. 2020 Sep 1. pii: 2004489117.
    >> Share

    August 2020
  132. SATHKUMARA HD, Muruganandah V, Cooper MM, Field MA, et al
    Mucosal delivery of ESX-1-expressing BCG strains provides superior immunity against tuberculosis in murine type 2 diabetes.
    Proc Natl Acad Sci U S A. 2020 Aug 10. pii: 2003235117.
    >> Share

  133. ANTONELLI AC, Binyamin A, Hohl TM, Glickman MS, et al
    Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-gamma signaling.
    Proc Natl Acad Sci U S A. 2020;117:18627-18637.
    >> Share

  134. PAPADOPOULOU M, Dimova T, Shey M, Briel L, et al
    Fetal public Vgamma9Vdelta2 T cells expand and gain potent cytotoxic functions early after birth.
    Proc Natl Acad Sci U S A. 2020;117:18638-18648.
    >> Share

  135. SPRENGER KG, Louveau JE, Murugan PM, Chakraborty AK, et al
    Optimizing immunization protocols to elicit broadly neutralizing antibodies.
    Proc Natl Acad Sci U S A. 2020 Aug 3. pii: 1919329117.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016